© 2021 AYAHUASCA GUIDES
Ayahuasca’s DMT effect on brainwaves
Beyer, S. (2008). Women and ayahuasca. Singing to the Plants. https://www.singingtotheplants.com/2008/02/women-and-ayahuasca/
Boyer, E. W., & Shannon, M. (2005). Serotonin Syndrome. The New England Journal of Medicine, 352, 1112-1120.
Brierly, D. I., & Davidson, C. (2012). Developments in harmine pharmacology-
implications for ayahuasca use and drug-dependence treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 39, 263-272.
Brown, C. H. (2010). Drug-induced serotonin syndrome. Medscape. Retrieved 02/27/2014 from http://www.medscape.com/viewarticle/733706_1
dos Santos, R. G. (2013a). A Critical Evaluation of Reports Associating Ayahuasca with Life- Threatening Adverse Reactions. Journal of Psychoac.ve Drugs, 45 (2), 179-188.
dos Santos, R. G. (2013b). Safety and side effects of ayahuasca in humans–an overview focusing on developmental toxicology. Journal of Psychoac.ve Drugs, 45 (1), 68-78.
Fischman, L. G. (1983). Dreams, hallucinogenic drug states, and schizophrenia: A psychological and biological comparison. Schizophrenia Bulle.n, 9 (1), 73-94.
Gable, R. S. (2007). Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids. Society for the Study of Addiction, 102, 24-34.
Guerra, I. (2010, March 23). Peru: Police arrests alleged rapist of German tourist. Living in Peru. Retrieved from http://archive.peruthisweek.com/news-11762-law-order-peru-police-arrests-alleged-rapist-german-tourist
Hearn, K. (2013, March). The dark side of ayahuasca. Men’s Journal. Retrieved from http://www.mensjournal.com/magazine/the-dark-side-of-ayahuasca-20130215
Johnson, M. W., Richards, W. A., & Griffiths, R. R. (2008). Human hallucinogen research: Guidelines for safety. Journal of Psychopharmacology, 22 (6), 603-620.
Kahn, M. (1997). Between Therapist and Client: The new relationship (Rev. ed.). New York, NY: W. H. Freeman and Company.
Labate, B. C. (2011). Consumption of ayahuasca by children and pregnant women: medical controversies and religious perspectives. Journal of Psychoac.ve Drugs, 43, (1), 27-35.
McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges. Pharmacology & Therapeutics, 102, 111-129.
Trichter, S. (2011, September 2). Ayahuasca: Beyond the Amazon risks and challenges of a spreading tradition. Retrieved from http://www.ayahuasca.com/psyche/risks-and-challenges-of-a-spreading-tradition/
Domínguez-Clavé, E., Soler, J., Elices, M., Pascual, J. C., Álvarez, E., de la Fuente Revenga, M., … Riba, J. (2016). Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Research Bulletin.
McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics, 102(2), 111–129.
Labate B.C. & Goldstein I. (2009) Ayahuasca – from dangerous drug to national heritage. Intl. J. of Transpersonal Studies, 28(1), 53-64.
McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics, 102(2), 111–129.
Riba, J., Romero, S., Grasa, E., Mena, E., Carrió, I., & Barbanoj, M. J. (2006). Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant. Psychopharmacology, 186(1), 93–98.
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003). Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics, 306(1), 73–83.
Brierley D.I. & Davidson C. (2012). Developments in harmine pharmacology. Prog. Neuro-Pharm. & Biol. Psychiatry, 39, 263-272.
Callaway, J. C., & Grob, C. S. (1998). Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. Journal of Psychoactive Drugs, 30(4), 367–369.
Riba, J., Valle, M., Urbano, G., Yritia, M., Morte, A., & Barbanoj, M. J. (2003). Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics, 306(1), 73–83.
Riba, J., Rodríguez-Fornells, A., Urbano, G., Morte, A., Antonijoan, R., Montero, M., … Barbanoj, M. J. (2001). Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology, 154(1), 85–95.
Tupper, K. W. (2009). Ayahuasca healing beyond the Amazon: The globalization of a traditional indigenous entheogenic practice. Global Networks, 9(1), 117–136.
McKenna, D. J. (2004). Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics, 102(2), 111–129.
Thomas et al. (2013). Ayahuasca-assisted therapy for addiction. Curr. Drug Abuse Rev, 6(1), 30-42.
Yakowicz, W. (2015, October 16). Silicon Valley’s Best-Kept Productivity Secret: Psychedelic Drugs.
LaVecchia, O. (2013, November 21). Ayahuasca Can Change Your Life — As Long as You’re Willing to Puke Your Guts Out.
Editor, A. B. A. R., & Post, T. H. (400AD, 26:54). Shaman Explains How Ayahuasca Can Facilitate A Spiritual Awakening.
Cohen, A. (2014, April 21). My Journey With a Life Altering Drug: Ayahuasca.
Hill, D. (2016, July 30). Ayahuasca is changing global environmental consciousness. The Guardian.
https://www.newyorker.com/magazine/2016/09/12/the-ayahuasca-boom-in-the-u-s
Carson, B., Sep. 8, 2016, 26, 047, & 5. (n.d.). This Silicon Valley angel investor loves a drug that gave him hours of seizures.
© 2021 AYAHUASCA GUIDES
DISCLAIMER: Ayahuasca is a potentially illegal substance, and we do not encourage or condone the use of this substance where it is against the law. However, we accept that illegal drug use occurs, and believe that offering responsible harm reduction information is imperative to keeping people safe. For that reason, this guide is designed to ensure the safety of those who decide to use the substance.
NO MEDICAL ADVICE
THE SITE MAY OFFER HEALTH, FITNESS, NUTRITIONAL AND OTHER SUCH INFORMATION, BUT SUCH INFORMATION IS DESIGNED FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY. THE INFORMATION CONTAINED ON THE SITE DOES NOT AND IS NOT INTENDED TO CONVEY MEDICAL ADVICE AND DOES NOT CONSTITUTE THE PRACTICE OF MEDICINE. YOU SHOULD NOT RELY ON THIS INFORMATION AS A SUBSTITUTE FOR, NOR DOES IT REPLACE, PROFESSIONAL MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT. WE ARE NOT RESPONSIBLE FOR ANY ACTIONS OR INACTION ON A USER’S PART BASED ON THE INFORMATION THAT IS PRESENTED ON THE SITE.